MapLight Therapeutics MPLT
NASDAQ MPLT
$7.52 +0.08 (+1.07%)
As of: Nov 11, 2026 · 3:38 PM EST

MapLight Therapeutics (MPLT) Depreciation and Depletion (2024 - 2026)

Updated

MapLight Therapeutics' Depreciation and Depletion came in at $162,000 for Q4 2025, down 16.5% from $194,000 a year earlier but up 62.0% from the prior quarter.

Analysis

MapLight Therapeutics (MPLT) Depreciation and Depletion (2024 - 2026) Analysis & Trends

For FY2025, MapLight Therapeutics' Depreciation and Depletion was $600,000, down 14.4% from FY2024.

  • Going back by year, Depreciation and Depletion was $701,000 in FY2024.
  • The five-year range for quarterly Depreciation and Depletion is $100,000 (Q3 2025) to $200,000 (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 MapLight Therapeutics 338.05 Mn 33.33 Mn - 147,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 147,000.00
Mar 31, 2026 162,000.00
Dec 31, 2025 162,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 136,000.00
Mar 31, 2025 166,000.00
Dec 31, 2024 194,000.00
Sep 30, 2024 200,000.00
API Access

MapLight Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=MPLT&period=max&api_key=YOUR_API_KEY